Journal article · 2025 · Open access

Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission

Xuepeng Wang, Baskar Ramdas, Ramesh Kumar, Ji Zhang, Reuben Kapur

Leukemia, 39(11), 2825–2829 · Published 16 September 2025 · DOI 10.1038/s41375-025-02770-9

Open PDFView at the publisherCite this paper

In brief

“Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission” is a 2025 journal article by Xuepeng Wang and 4 co-authors, published in Leukemia. OpenAlex counts 1 citations as of 18 November 2026, which puts it in the top 9% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Leukemia.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.62
References
16
Authors
5

Abstract

Ex vivo expansion of hematopoietic stem cells (HSCs) is limited by mitochondrial stress-induced loss of stemness. To identify protective mechanisms resembling the hypoxic bone marrow niche, we performed single-cell transcriptomics on hypoxia-collected HSCs, revealing significant downregulation of Rho-associated kinase 1 (ROCK1). This observation suggested ROCK1 as a potential regulator of HSC homeostasis. We tested this by genetically or pharmacologically inhibiting ROCK1 with shRNA or Y27632, which reduced mitochondrial reactive oxygen species, mitochondrial mass, and membrane potential while promoting expansion of phenotypic HSCs (Lin⁻CD34⁺CD38⁻CD45RA⁻CD49f⁺CD90⁺). Mechanistically, ROCK1 inhibition attenuated DRP1-mediated mitochondrial fission by decreasing p-DRP1(Ser616) and increasing p-DRP1(Ser637), thereby reducing mitochondrial fragmentation. Additionally, ROCK1 inhibition elevated BCL2 expression and reduced active Caspase-3 levels, indicating suppressed apoptosis. Limiting dilution transplants demonstrated a fourfold increase in functional HSC frequency following ROCK1 inhibition, with enhanced long-term engraftment in secondary recipients. Our findings identify ROCK1 as a critical regulator of mitochondrial dynamics in HSCs and provide a mechanistic basis for targeting ROCK1 to enhance functional HSC expansion, offering a promising strategy to improve outcomes in HSC transplantation by mimicking hypoxic niche signals ex vivo.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wang, X., Ramdas, B., Kumar, R., Zhang, J., & Kapur, R. (2025). Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission. Leukemia, 39(11), 2825–2829. https://doi.org/10.1038/s41375-025-02770-9

MLA 9

Wang, Xuepeng, et al. “Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission.” Leukemia, vol. 39, no. 11, 2025, pp. 2825–2829. https://doi.org/10.1038/s41375-025-02770-9.

Chicago

Wang, Xuepeng, Baskar Ramdas, Ramesh Kumar, Ji Zhang, and Reuben Kapur. 2025. “Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission.” Leukemia 39 (11): 2825–2829. https://doi.org/10.1038/s41375-025-02770-9.

Harvard

Wang, X. et al. (2025) ‘Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission’, Leukemia, 39(11), pp. 2825–2829. doi:10.1038/s41375-025-02770-9.

IEEE

X. Wang, B. Ramdas, R. Kumar, J. Zhang, and R. Kapur, “Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission,” Leukemia, vol. 39, no. 11, pp. 2825–2829, 2025, doi: 10.1038/s41375-025-02770-9.

BibTeX

@article{wang2025suppression,
  title     = {{Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission}},
  author    = {Wang, Xuepeng and Ramdas, Baskar and Kumar, Ramesh and Zhang, Ji and Kapur, Reuben},
  journal   = {Leukemia},
  year      = {2025},
  volume    = {39},
  number    = {11},
  pages     = {2825--2829},
  doi       = {10.1038/s41375-025-02770-9},
  url       = {https://doi.org/10.1038/s41375-025-02770-9}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation

  • hematopoietic stem cells
  • ex vivo HSC expansion
  • mitochondrial fission
  • Drp1 phosphorylation
  • mitochondrial dynamics
  • reactive oxygen species
  • mitochondrial membrane potential
  • Bcl-2

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Wang, X., Ramdas, B., Kumar, R., Zhang, J., & Kapur, R. (2025). Suppression of Rho-associated kinase 1 (ROCK1) promotes human hematopoietic stem cell expansion by attenuating mitochondrial fission. Leukemia, 39(11), 2825–2829. https://doi.org/10.1038/s41375-025-02770-9

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Leukemia: sign in and open the PDF from this page.

Who wrote this paper?

Xuepeng Wang, Baskar Ramdas, Ramesh Kumar, Ji Zhang, Reuben Kapur.

What is the DOI of this paper?

10.1038/s41375-025-02770-9, permanently at https://doi.org/10.1038/s41375-025-02770-9. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.